Year to Date Gross Profit Compared with Gross Loss in Prior-Year Period Nine-Month Net Loss Decreases 40 Emperor Total Artificial Heart Development Advances, with Drive-System Testing Exceeding 18 Million Operating Cycle
Why Is Picard Medical, Inc. (PMI) Stock Down Today?
Updated Nov 20, 2026 5:22 AM ET · Prev Close $6.44
Session Regime & Catalyst Assessment
68% Signal ConvictionPicard Medical, Inc. Pulling Back 2.17% on 0.34x Relative Volume
Picard Medical, Inc. (PMI) is pulling back 2.17% (-$0.14) to $6.30 on 0.34x average session volume. Relative to benchmarks, PMI is trading in line with the S&P 500 (-0.21% alpha). 14-day RSI stands at 42.1, keeping momentum in a bearish regime.
Year to Date Gross Profit Compared with Gross Loss in Prior-Year Period Nine-Month Net Loss Decreases 40 Emperor Total Artificial Heart Development Advances, with Drive-System Testing Exceeding 18 Million Operating Cycle
Price ($6.30) trades relative to 20-day SMA ($7.55) and 50-day SMA ($7.62).
Market & Sector Relative Strength
PMI trading in line with the S&P 500 (-0.21% alpha)Recent PMI Catalyst Headlines
Verified WirePicard Medical Inc. AMEX Pmi shares surged nearly 43.
Claritev Corporation CTEV delivered earnings and revenue surprises of 1.09 and 4.51 , respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
CareCloud CCLD delivered earnings and revenue surprises of 16.67 and 0.69 , respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
1–3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $6.28 (session support) for directional breakout confirmation.
Technical Regime (PMI)
BEARISH MA TRENDRetail & Crowd Sentiment
NeutralSCAG's stock price may experience positive momentum following the announcement of a strategic cooperation agreement with China Huaye Group.
About Picard Medical, Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed …
Get Instant PMI Catalyst Alerts
Receive an email alert when PMI triggers an unusual volume breakout, options sweep, or rating shift.
Other Liquid Stocks Moving Today
All Today's MoversPMI Session & Catalyst FAQ
Why is PMI stock down today?
Picard Medical, Inc. (PMI) is pulling back 2.17% (-$0.14) to $6.30 on 0.34x average session volume. Relative to benchmarks, PMI is trading in line with the S&P 500 (-0.21% alpha). 14-day RSI stands at 42.1, keeping momentum in a bearish regime.
Is PMI stock a buy or sell right now?
Today's session carries a 68% catalyst conviction score on 0.34x relative volume (low participation). Our multi-factor model currently rates PMI as HOLD. Review full valuation, quality, and timing signals on the PMI Buy or Sell Decision Brief →
What is PMI's intrinsic value and expected trading range?
At $6.30, PMI's modeled 1-to-3 session range is $6.00 – $6.60, with a key inflection level at $6.28 (session support). Compare current price against multi-year cash flow projections in the PMI Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →
What do RSI and moving averages signal for PMI?
RSI at 42.1 reflects soft below-midline momentum. PMI trades at $6.30 relative to its 20-day SMA ($7.55) and 50-day SMA ($7.62), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.